Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Nektar Withdraws Oxycodegol NDA As Novel Submission Pileup Continues

Jan 20 2020

• By Michael Cipriano

Keeping Track Feature image

Related Content

Nektar's Novel Opioid Unanimously Rejected by US FDA Advisory Cmte.

Jan 15 2020

EU 2019 Approvals: Novel Therapies Make Strong Showing

Jan 14 2020

Keeping Track: Bad News For Bristol And Lilly, Good News For TG Therapeutics

Jan 27 2019

Keeping Track: A Busy Week For Regenerative Medicine, A Surprise Priority Review For Vascepa, And Tazemetostat Aims For Accelerated Approval

Jun 02 2019

One Loss, One Tie: US FDA Panels Prove Difficult For Opioid Sponsors Intellipharmaceutics, Esteve

Jan 16 2020

Nektar's Novel Opioid For Lower Back Pain Heads To US FDA Panel For Wide-Ranging Discussion

Jan 14 2020

Keeping Track: Mycapssa Stumbles; Carnexiv Returns; Keytruda Follows Opdivo In Hodgkin Lymphoma

Apr 25 2016

Keeping Track: A Burst Of Breakthroughs, A Priority Review For Keytruda, And Some Supplemental Submissions

Mar 19 2018

Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels

Dec 18 2019

Tesaro's On The Right Path With Anti-PD-1 Dostarlimab In Endometrial Cancer

Mar 22 2019

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

New Front Opens in First-Line Ovarian Cancer Market: GSK’s Zejula Vs. AZ’s Lynparza

Sep 29 2019

BMS Ready To Pounce On Non-Chemo Opportunity In Lung Cancer With Checkmate-227 Data

Jul 25 2019

TG’s Follicular Lymphoma Data Suggest Umbralisib Could Succeed In PI3K Delta Class

Oct 28 2019

First-Line Chemo Combo Data Help Merck's Keytruda Power Past Opdivo

Jul 30 2018

Related Companies

GSK plc

Genetix Biotherapeutics

Alnylam Pharmaceuticals Inc.

Sarepta Therapeutics, Inc.

TG Therapeutics, Inc.

Bristol Myers Squibb Company

Chiasma, Inc.

Esteve Pharmaceuticals, S.A.

Intellipharmaceutics International Inc.

Merck & Co., Inc.

BioMarin Pharmaceutical Inc.

Kite Pharma, Inc.

Ferring Pharmaceuticals

Dicerna Pharmaceuticals, Inc.

OxThera AB

Bristol Myers Squibb Company

Pharmacyclics, Inc.

Novartis AG

AstraZeneca PLC

Additional Topics

United States Drug Review Regulation US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window